posologie cialis 5mg https://projectathena.org/grandmedicine/abilify-cyp2d6/11/ https://medpsychmd.com/nurse/getting-prednisone/63/ case study on chloride content in water case study house no 22 https://goodbelly.com/rxpack/cialis-obat-perkasa-alami/32/ https://makeitinla.org/writer/alzheimers-thesis-paper/32/ follow see url cheap mba essay proofreading site au master thesis work sweden see url here can you buy viagra ireland https://rainierfruit.com/viagra-not-safe/ power meds order cialis online essays on teenagers and birth control purdue dissertation template follow url essay on hindi about christmas viagra natural alimentos harvard referencing a website in an essay tomar viagra con alcohol ace malo example of a literary essay https://smartfin.org/science/medicamentos-cialis-diario/12/ https://plastic-pollution.org/trialrx/similares-do-viagra-expire/31/ direct dimethyl ether essay https://smartfin.org/science/cialis-tablet-10-mg/12/ enter source url go to link https://medpsychmd.com/nurse/viagra-online-is-it-safe/63/ Otolith Labs
Solving Vertigo and Motion Sickness
Otolith Labs is pioneering the first medical wearable for the treatment of vertigo, a symptom experienced by more than 15 million Americans. Otolith’s patented non-invasive head-worn technology uses precisely tuned vibrations to interact with the motion sensors in the inner ear, mitigating the symptoms of vertigo and motion sickness. This novel technology has been validated by several clinical studies, including multiple independent studies at universities and with leading automotive manufacturers. Otolith plans to submit to the FDA for 510(k) De Novo approval in 2022.
Founder & CEO
Didier Depireux, Ph.D
Chief Science Officer
Chief Product Officer
Chief Business Officer
Chief Operating Officer
Regulatory Compliance Engineer
Clinical Research Associate
Six Years In The Making
Otolith Lab’s was founded in 2015 by Sam Owen, while Sam was pursuing a PHD in Physics at Georgetown University. Shortly after founding the company, Otolith Labs was accepted into the Halcyon incubator, a startup incubator focused on scalable and sustainable ventures which have a positive impact. In 2016, Otolith conducted its first clinical study and in 2018, Land Rover Jaguar validated the technology in the treatment of Motion Sickness. In 2020, Otolith won the Ignite the Night competition at CES and prestigious NASA iTech Prize.
Otolith Labs is backed by experienced medical investors, including several Ear, Nose and Throat Doctors, and has been awarded multiple contracts by the U.S. Defense Department to evaluate its technology. The company is based in Washington, D.C.
“Otolith Labs was founded to help the more than 15 million Americans who have chronic difficulties relating to balance and vertigo with simple, non-invasive technology. We are committed to solving this common health challenge.“
Founder & CEO
Otolith Labs believes the strength of our company lies with our team of hardworking talent in the scientific, engineering, and business development spaces. We strive to work with a diverse group of people, with different backgrounds, thinking, and skills, to create an environment where innovation thrives. Our team is committed to helping mitigate the effects of vertigo because we understand the difficulties suffered and the future we can help shape.
We work together and support one another to foster a culture where creativity and innovation flourish.
Through years of research and development, we are pioneering the first wearable medical device to treat vertigo.
Creating Life-Changing Solutions
Our team is passionate and sincere about developing a product that will improve millions of lives.